Juniper Pharmaceuticals (JNP), Inc
Boston, Massachusetts, United States of America
Description:
Juniper Pharmaceuticals (Nasdaq: JNP) is developing therapeutics that address unmet medical needs in women’s health. Our current pipeline leverages the 505(b)(2) regulatory pathway with new formulations of existing pharmaceuticals.
The Company has a successful history in developing pharmaceutical products, including Crinone® 8% (progesterone gel), which is commercially available in the United States and over 90 countries around the world.
Juniper Pharmaceuticals (Nasdaq: JNP) is developing therapeutics that address unmet medical needs in women’s health. Our current pipeline leverages the 505(b)(2) regulatory pathway with new formulations of existing pharmaceuticals.
The Company has a successful history in developing pharmaceutical products, including Crinone® 8% (progesterone gel), which is commercially available in the United States and over 90 countries around the world.
Quick Links
Connect With Us
Awards & Recognitions
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com